Similar Items: Dosimetry of [Lu]Lu-PSMA therapy in a hemodialysis patient: a case study
- Fractionation gives therapeutic benefit in animal model of [Lu]Lu-PSMA-617 therapy of prostate cancer
- Outcome and safety of single-dose docetaxel–augmented targeted radionuclide therapy using [¹⁷⁷Lu]Lu-PSMA-617 radioligand therapy in treatment-refractory mCRPC: preliminary evidence from a pilot experience
- Correction: Combined antitumor activity of [177Lu]Lu-FAPI-2286 and pazopanib in a sarcoma model: a preclinical theranostic study targeting fibroblast activation protein
- Emerging need of dosimetry in radioligand therapy: a feasible method tested in a large cohort of patients affected by neuroendocrine neoplasms
- Preclinical in vivo dosimetry of healthy tissues in radiopharmaceutical therapy: implementation of a physiologically realistic mouse eye model in GATE
- Myostatin and Sarcopenia in Elderly Among Hemodialysis Patient